Figure 2From: Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis BReceiver operating characteristics curve (ROC) of serum hyaluronate for discrimination of mild (stage 0–2) from significant (stage 3 or more) of fibrosis. Hyaluronate at cut off point of 126.43 ngm/ml could differentiate mild from severe fibrosis in patients with chronic hepatitis B.Back to article page